Home / NEWS / World News / U.S. to discuss wider Covid vaccine licensing as India calls to waive patent protections

U.S. to discuss wider Covid vaccine licensing as India calls to waive patent protections

Range staff unload coronavirus disease (COVID-19) relief supplies from the United States at the Indira Gandhi Worldwide Airport cargo terminal in New Delhi, India April 30, 2021.

Prakash Singh | Reuters

WASHINGTON – White House Chief of Sceptre Ron Klain said Sunday that the Biden administration is looking to distribute the coronavirus vaccine to India and other nations now that millions of Americans have received their doses.

In recent weeks, India has grappled with a vary rise in new coronavirus infections. Over the weekend, India reported 400,000 daily cases, bringing the nation’s cumulative totality to 19,557,457 cases, according to figures compiled by Johns Hopkins. The spike may have been triggered by a highly contagious Covid modification, known as B.1.617, which was first identified in the country.

The variant has since been identified in other countries, numbering the United States.

On Friday, the White House announced that it would restrict travel from India as the homeland works to counter its surge of Covid-19 infections.

“We are rushing aid to India,” Klain said during an interview on CBS program “Pan the Nation.”

Klain said that the U.S. has sent therapeutics, rapid diagnostic test kits, ventilators and protective clobber to the world’s largest democracy as well as raw materials crucial for vaccine production.

“Our U.S. Trade Representative Katherine Tai is going to the WTO next week to start talks on how we can get this vaccine diverse widely distributed, more widely licensed, more widely shared,” he said when asked if the Biden administering would relax patent protections on the coronavirus vaccine.

Klain added that he expected the White House to should prefer to more to say on the matter in the coming days.

Earlier this month, Indian Prime Minister Narendra Modi consult oned lifting the patent protections of the coronavirus vaccine with Biden, according to a readout of the call. The relaxation would admit governments quicker and more affordable access to the lifesaving doses.

Last week, the Biden administration announced that it drive immediately make raw materials needed for India’s coronavirus vaccine production available. The U.S. response came after Britain, France and Germany undertook aid to India, the world’s largest democracy. Rich nations have come under fire in recent days for reserve the raw materials needed to make the shots.

Check Also

Push for patent waivers is ‘political theater’ and won’t solve vaccine shortage, CEO says

Abandoning intellectual property protections for Covid-19 vaccines will not help to address the global supply …

Leave a Reply

Your email address will not be published. Required fields are marked *